Medicaid Provider Spending

$1.09 trillion in Medicaid claims data, 2018–2024 · 617K+ providers

TOTAL WELLNESS CENTERS, LLC

NPI: 1770020018 · HOLYOKE, MA 01040 · Clinical Medical Laboratory · NPI assigned 01/25/2017

$77.17M
Total Medicaid Paid
1,875,235
Total Claims
1,007,754
Beneficiaries
20
Codes Billed
2018-01
First Month
2024-12
Last Month

Provider Details

Authorized OfficialSMOLAREK, MATTHEW (CFO)
NPI Enumeration Date01/25/2017

Related Entities

Other providers sharing the same authorized official: SMOLAREK, MATTHEW

ProviderCityStateTotal Paid
CLEANSLATE MEDICAL GROUP OF INDIANA LLC ALEXANDRIA IN $79.21M
TOTAL WELLNESS CENTERS, LLC WEST SPRINGFIELD MA $38.42M
CLEANSLATE MEDICAL GROUP OF PENNSYLVANIA LLC WILKES BARRE PA $18.61M
CLEANSLATE MEDICAL GROUP OF WISCONSIN, SC GLENDALE WI $17.13M
CLEANSLATE MEDICAL GROUP OF KENTUCKY PLLC LOUISVILLE KY $10.48M
CLEANSLATE MEDICAL GROUP OF OHIO LLC MORAINE OH $9.53M
CLEANSLATE MEDICAL GROUP OF VIRGINIA, LLC MECHANICSVILLE VA $4.28M
CLEANSLATE MEDICAL GROUP OF ARIZONA PLLC GILBERT AZ $955K
CLEANSLATE MEDICAL GROUP OF ARIZONA PLLC PHOENIX AZ $248K
CLEANSLATE MEDICAL GROUP OF ARIZONA PLLC PHOENIX AZ $101K

Monthly Spending Trend

Yearly Breakdown

YearClaimsTotal Paid
2018 163,968 $2.99M
2019 204,646 $5.55M
2020 244,578 $9.15M
2021 302,013 $13.24M
2022 349,243 $16.83M
2023 359,084 $17.24M
2024 251,703 $12.18M

Billing Codes

CodeDescriptionClaimsBeneficiariesTotal Paid
80307 Drug test(s), presumptive, any number of drug classes; immunoassay 1,427,316 643,621 $60.65M
G0480 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed 279,181 213,042 $13.80M
99214 Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity 7,628 4,794 $760K
87389 Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies 42,469 38,770 $690K
86803 42,701 38,962 $415K
99213 Office or other outpatient visit for the evaluation and management of an established patient, low complexity 5,507 4,071 $392K
87340 43,569 39,818 $316K
80076 15,492 14,153 $51K
90832 Psychotherapy, 30 minutes with patient 924 764 $48K
ATP07 6,265 6,223 $31K
90791 Psychiatric diagnostic evaluation 61 61 $8K
36415 Collection of venous blood by venipuncture 2,439 2,361 $3K
96372 Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular 137 130 $3K
99204 Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity 13 13 $2K
90834 Psychotherapy, 45 minutes with patient 13 12 $1K
86704 112 105 $1K
99000 261 88 $1K
86706 93 86 $757.03
81025 97 88 $461.85
H0003 Alcohol and/or drug screening; laboratory analysis of specimens for presence of alcohol and/or drugs 957 592 $2.80